Cargando…
Delineation of the distinct inflammatory signaling roles of TAK1 and JAK1/3 in the CIA model of rheumatoid arthritis
Rheumatoid arthritis (RA) is a complex autoimmune disease characterized by hyperactive immune cells within the joints, which leads to inflammation, bone degeneration, and chronic pain. For several decades, frontline immunomodulators such as the anti‐tumor necrosis factor (TNF) biologics adalimumab (...
Autores principales: | Freeze, Robert, Yang, Kelly W., Haystead, Timothy, Hughes, Philip, Scarneo, Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415874/ https://www.ncbi.nlm.nih.gov/pubmed/37564034 http://dx.doi.org/10.1002/prp2.1124 |
Ejemplares similares
-
Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice
por: Scarneo, Scott A., et al.
Publicado: (2019) -
TAK1 regulates the tumor microenvironment through inflammatory, angiogenetic and apoptotic signaling cascades
por: Scarneo, Scott A., et al.
Publicado: (2020) -
TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases
por: Totzke, Juliane, et al.
Publicado: (2020) -
Pharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosis
por: Bale, Swarna, et al.
Publicado: (2023) -
Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion
por: Scarneo, Scott A., et al.
Publicado: (2018)